The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b

Infection and Immunity

Volumn 79, Issue 12, 2011, Pages 4784-4790

  Shames, Stephanie R ^a,b   Croxen, Matthew A ^a   Deng, Wanyin ^a   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIAL PROTEIN; CARRIER PROTEIN; PROTEIN ESPZ; TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17B; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; ESPZ PROTEIN, E COLI; SMALL INTERFERING RNA; TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17B PROTEIN, HUMAN;

ARTICLE; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ESCHERICHIA COLI INFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; CELL LINE; CLASSIFICATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

CELL LINE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84855743977     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05761-11     Document Type: Article

References (30)

1. Babic, A., A. M. Guerout, and D. Mazel. 2008. Construction of an improved RP4 (RK2)-based conjugative system. Res. Microbiol. 159:545-549.
2. Baruch, K., et al. 2011. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J. 30:221-231.
3. Bauer, M. F., et al. 1999. Genetic and structural characterization of the human mitochondrial inner membrane translocase. J. Mol. Biol. 289:69-82.
4. Bomer, U., et al. 1996. The preprotein translocase of the inner mitochondrial membrane: evolutionary conservation of targeting and assembly of Tim17. J. Mol. Biol. 262:389-395.
5. Chacinska, A., C. M. Koehler, D. Milenkovic, T. Lithgow, and N. Pfanner. 2009. Importing mitochondrial proteins: machineries and mechanisms. Cell 138:628-644.
6. Chacinska, A., et al. 2005. Mitochondrial presequence translocase: switching between TOM tethering and motor recruitment involves Tim21 and Tim17. Cell 120:817-829.
7. Cossarizza, A., M. Baccarani-Contri, G. Kalashnikova, and C. Franceschi. 1993. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197:40-45.
8. Croxen, M. A., and B. B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38.
9. Deng, W., et al. 2005. Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect. Immun. 73:2135-2146.
10. Deng, W., et al. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101:3597-3602.
11. Frazier, A. E., et al. 2003. Mitochondria use different mechanisms for transport of multispanning membrane proteins through the intermembrane space. Mol. Cell. Biol. 23:7818-7828.
12. Golstein, P., and G. Kroemer. 2007. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32:37-43.
13. Hemrajani, C., et al. 2010. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U. S. A. 107:3129-3134.
14. Holmes, A., S. Muhlen, A. J. Roe, and P. Dean. 2010. The EspF effector, a bacterial pathogen's Swiss army knife. Infect. Immun. 78:4445-4453.
15. Iguchi, A., et al. 2009. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J. Bacteriol. 191:347-354.
16. Kanack, K. J., J. A. Crawford, I. Tatsuno, M. A. Karmali, and J. B. Kaper. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect. Immun. 73: 4327-4337.
17. Kenny, B., et al. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
18. Kurushima, J., T. Nagai, K. Nagamatsu, and A. Abe. 2010. EspJ effector in enterohemorrhagic E. coli translocates into host mitochondria via an atypical mitochondrial targeting signal. Microbiol. Immunol. 54:371-379.
19. Levine, M. M., et al. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:1119-1122.
20. Ma, C., et al. 2006. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell. Microbiol. 8:1669-1686.
21. Martinez-Caballero, S., S. M. Grigoriev, J. M. Herrmann, M. L. Campo, and K. W. Kinnally. 2007. Tim17p regulates the twin pore structure and voltage gating of the mitochondrial protein import complex TIM23. J. Biol. Chem. 282:3584-3593.
22. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
23. Nagai, T., A. Abe, and C. Sasakawa. 2005. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 280:2998-3011.
24. Nougayrede, J. P., and M. S. Donnenberg. 2004. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 6:1097-1111.
25. Papatheodorou, P., et al. 2006. The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology. Cell. Microbiol. 8:677-689.
26. Samba-Louaka, A., J. P. Nougayrede, C. Watrin, E. Oswald, and F. Taieb. 2009. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect. Immun. 77:5471-5477.
27. Sham, H. P., et al. 2011. The attaching/effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-{kappa}B and p38-MAP kinase activation. Infect. Immun. 79:3552-3562.
28. Shames, S. R., et al. 2010. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signaling. Cell. Microbiol. 12:1322-1339.
29. Smiley, S. T., et al. 1991. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. U. S. A. 88:3671-3675.
30. Tobe, T., et al. 2006. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc. Natl. Acad. Sci. U. S. A. 103:14941-14946.